A Study of Erlotinib After Surgery With or Without Adjuvant Chemotherapy in NSCLC Patients Who Have EGFR-Positive Tumors
More Information
We appreciate you taking the time to visit this website.
If you have any questions or would like further information please consult with your Health Care Provider in the first instance, but also please feel free to contact us via the following:
By telephone:
| Within USA/Canada: | 1 800 572 1932 (ask for extension 7821) |
| From outside of USA/Canada: | 001 800 572 1932 (ask for extension 7821) |
By email:
A representative of OSI Medical Information will respond to your enquiry as soon as possible but please allow for the time zone differences, especially if you are contacting us from outside of North America.
Which Institutions are participating in this study?
If you are interested in finding out if there is a participating hospital or clinic in your local area or country, please contact us or check the following link to clinicaltrials.gov
email us:
For More Information Call:
+1-800-572-1932
and dial extension 7821
© OSI Pharmaceuticals, Inc. 2008 | Terms and Conditions | Privacy Policy